LifeStance Health Group Inc (NASDAQ:LFST) shares, rose in value, with the stock price up by 0.65% to the previous day’s close as strong demand from buyers drove the stock to $6.20.
Actively observing the price movement in the last trading, the stock closed the session at $6.16. Referring to stock’s 52-week performance, its high was $9.59, and the low was $4.74. On the whole, LFST has fluctuated by 2.99% over the past month.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 1.22B, with a low estimate of 296.73M and a high estimate of 303.07M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 298.99M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that LFST’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of LFST currently trading nearly 3.00% and -4.10% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 52.62, while the 7-day volatility ratio is showing 4.15% which for the 30-day chart, stands at 3.95%. Furthermore, LifeStance Health Group Inc (LFST)’s beta value is 1.29, and its average true range (ATR) is 0.26.
A comparison of LifeStance Health Group Inc (LFST) with its peers suggests the former has fared considerably weaker in the market. LFST showed an intraday change of 0.65% in last session, and over the past year, it shrunk by -20.72%%.
Data on historical trading for LifeStance Health Group Inc (NASDAQ:LFST) indicates that the trading volumes over the past 3 months, they’ve averaged 1.35 million. According to company’s latest data on outstanding shares, there are 378.73 million shares outstanding.
Nearly 77.42% of LifeStance Health Group Inc’s shares belong to company insiders and institutional investors own 23.54% of the company’s shares. The stock has fallen by -20.82% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the LFST stock heading into the next quarter.
